Trump Thanks India For Decision On Anti-Malaria Drug

President Donald Trump on Wednesday thanked India for its decision to increase exports of the anti-malaria drug hydroxychloroquine, an unproven treatment that Trump has promoted in the fight against the novel coronavirus.

India said on Tuesday it will allow some exports of hydroxychloroquine after Trump urged New Delhi to release supplies of the drug seen as a possible treatment for COVID-19.

“Extraordinary times require even closer cooperation between friends. Thank you India and the Indian people for the decision on HCQ. Will not be forgotten! Thank you Prime Minister @NarendraModi for your strong leadership in helping not just India, but humanity, in this fight!” Trump wrote on Twitter.

Recent Posts

  • Featured

‘PM Modi Wants Youth Busy Making Reels, Not Asking Questions’

In an election rally in Bihar's Aurangabad on November 4, Congress leader Rahul Gandhi launched a blistering assault on Prime…

10 hours ago
  • Featured

How Warming Temperature & Humidity Expand Dengue’s Reach

Dengue is no longer confined to tropical climates and is expanding to other regions. Latest research shows that as global…

14 hours ago
  • Featured

India’s Tryst With Strategic Experimentation

On Monday, Prime Minister Narendra Modi launched a Rs 1 lakh crore (US $1.13 billion) Research, Development and Innovation fund…

14 hours ago
  • Featured

‘Umar Khalid Is Completely Innocent, Victim Of Grave Injustice’

In a bold Facebook post that has ignited nationwide debate, senior Congress leader and former Madhya Pradesh Chief Minister Digvijaya…

1 day ago
  • Featured

Climate Justice Is No Longer An Aspiration But A Legal Duty

In recent months, both the Inter-American Court of Human Rights (IACHR) and the International Court of Justice (ICJ) issued advisory…

2 days ago
  • Featured

Local Economies In Odisha Hit By Closure Of Thermal Power Plants

When a thermal power plant in Talcher, Odisha, closed, local markets that once thrived on workers’ daily spending, collapsed, leaving…

2 days ago

This website uses cookies.